Propyliodone is used as a bronchographic contrast agent. Compared with iodized oil, it has fewer adverse reactions, is less likely to cause acute pulmonary inflammation or granuloma, and has a lower incidence of allergic reactions and better tolerability. It is administered via local instillation as a 50% aqueous suspension or 60% oily suspension (12–18 mL) for bronchography, with optimal imaging achieved approximately 30 minutes after administration. It is particularly useful in selective bronchography under fiberoptic bronchoscopy, enabling detailed visualization of bronchial morphology down to the 9th–10th generation bronchi and even alveoli. It can also be used in patients with active pulmonary tuberculosis.